Feasibility and clinical outcomes in nonagenarians undergoing transcatheter aortic valve replacement with the LOTUSTM valve  

作　　者：Satish Ramkumar Hashrul N Rashid Sarah Zaman Liam McCormick Robert Gooley Damon Jackson Ian T Meredith 

机构地区：[1]MonashHEART, Monash Health, Melbourne, Victoria, Australia [2]Monash Cardiovascular Research Centre, Monash University, Melbourne, Victoria, Australia

出　　处：《Journal of Geriatric Cardiology》2016年第7期636-638,共3页老年心脏病学杂志（英文版）

摘　　要：Surgical aortic valve replacement （AVR） is associated with very high peri-operative risk in the nonagenarian populationflI Patients with severe aortic stenosis treated conservatively have high rates of mortality with poor quality of life and loss of independence. Transcatheter aortic valve replacement （TAVR） has been validated in the high risk elderly population as a viable alternative to surgery with comparable outcomes.

关 键 词：Aortic valve replacement Nonagenarian patients Transcatheter aortic valve replacement 

分 类 号：R[医药卫生]